酸性神经鞘磷脂酶(ASM)真核蛋白
Eukaryotic Acid Sphingomyelinase (ASM)
SMPD1; NPD; SMase; aSMase; Sphingomyelin Phosphodiesterase 1,Acid Lysosomal; Simply Sphingomyelinase
- 编号EPB360Hu61
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源真核表达
- 宿主293F cell
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位溶酶体
- 预测分子量64.9kDa
- 实际分子量75kDa(差异分析请参阅说明书)
- 片段与标签His62~Pro628 with N-terminal His Tag
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性状冻干粉
- 纯度> 95%
- 等电点7.2
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1680 ¥ 4200 ¥ 8400 ¥ 25200 ¥ 63000
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
EPB360Hu61 | 酸性神经鞘磷脂酶(ASM)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB360Hu01 | 酸性神经鞘磷脂酶(ASM)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB360Hu61 | 酸性神经鞘磷脂酶(ASM)活性蛋白 | Cell culture; Activity Assays. |
PAB360Hu01 | 酸性神经鞘磷脂酶(ASM)多克隆抗体 | WB; IHC; ICC; IP. |
MAB360Hu22 | 酸性神经鞘磷脂酶(ASM)单克隆抗体 | WB; IHC; ICC; IP. |
SEB360Hu | 酸性神经鞘磷脂酶(ASM)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
MEB360Hu | 酸性神经鞘磷脂酶(ASM)检测试剂盒(酶联免疫吸附试验法,小样本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB360Hu | 酸性神经鞘磷脂酶(ASM)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Blood.? | Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD [Pubmed:25075126] |
Journal of Clinical Lipidology | Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes [10.1016/j.jacl.2017.03.007] |
Diabetes & metabolism | Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD? [pubmed:28499696] |
INFLAMMATION | Acid Sphingomyelinase and Acid ¦Â-Glucosidase 1 Exert Opposite Effects on Interleukin-1¦Â-Induced Interleukin 6 Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes [33665756] |
Indian J Ophthalmol | Evaluation of sphingolipid metabolism on diabetic retinopathy [34708809] |
留言咨询